A comparison of the tumor growth inhibitory effect of intermittent and continuous administration of the somatostatin structural derivative TT-232 in various human tumor models.

Source:http://linkedlifedata.com/resource/pubmed/id/16886628

Download in:

View as

General Info

PMID
16886628